Abstract: Lung injury in trauma patients exposed to a secondary infectious/septic challenge contributes to the high morbidity/mortality observed in this population. Associated pathology involves a dys-regulation of immune function, specifically, sequestration of activated polymorphonuclear neutrophils (PMN) in the lungs. The targeting of PMN is thought to involve the release of chemokines from cells within the local environment, creating a concentration gradient along which PMN migrate to the focus of inflammation. Keratinocyte-derived chemokine (KC) and macrophage-inflammatory protein-2 (MIP-2) are murine neutrophil chemokines identified as playing significant but potentially divergent roles in the pathogenesis of acute lung injury (ALI). In the current study, we examined the contribution of local pulmonary cells to the production of KC and MIP-2 and the pathogenesis of ALI. We hypothesized that local silencing of KC or MIP-2, via the local administration of small interference RNA (siRNA) against KC or MIP-2, following traumatic shock/hemorrhage (Hem), would suppress signaling for PMN influx to the lung, thereby reducing ALI associated with a secondary septic challenge (cecal ligation and puncture). 
INTRODUCTION
Despite an increased understanding of the myriad of mediators and pathways associated with the pathogenesis of acute lung injury (ALI), the heterogeneity of the patient population presents a confounding problem in the advancement of new therapies. Mortality among trauma patients remains high (Ͼ40%) [1] . Treatment costs associated with ALI account for 34% of trauma treatment costs, despite representing 16% of the trauma patient population [2, 3] . ALI is a progressive syndrome along a continuum of pathological inflammatory responses leading to acute respiratory distress syndrome, lung tissue damage, and ultimately, organ failure [4] . Hemorrhagic shock, trauma, and burns are among the predisposing factors associated with the pathogenesis of ALI [5, 6] . Predisposition or the priming of the immune response has been found to be crucial in the development of an exaggerated/dys-regulated inflammatory response and ensuing lung injury, which is characteristic of ALI [7] [8] [9] [10] [11] [12] [13] .
The clinical pathology of ALI includes increased microvascular permeability, inflammation, pulmonary edema, and the accumulation of activated neutrophils in lung tissue and bronchoalveolar lavage fluid [4, 14 -16] . The finding of significant numbers of activated/sequestered neutrophils in the lungs of patients with ALI has focused our research on the contribution of neutrophils and their mediators in the pathogenesis of this syndrome [5, 7, 8, 10, [17] [18] [19] [20] [21] . The targeting of neutrophils to the lungs is thought to be, in part, mediated by local chemokine production [4, 12, 17, 18, 22] . We have previously reported a significant increase in lung tissue levels of keratinocyte derived-chemokine (KC) and macrophage inflammatory protein-2 (MIP-2), murine neutrophil chemoattractants, in our mouse model of hemorrhage priming for ALI [19, 23] . Subsequent antibody neutralization of MIP-2 or KC immediately following hemorrhage significantly reduced lung tissue levels of these chemokines and neutrophil influx to the lung following a secondary/triggering insult, sepsis. In addition, preliminary studies by our laboratory examining neutrophil migration in macrophage-deficient mice (B6C3Fe-a/a-CsF1op) found local production of chemokines to be critical to the targeting of neutrophils to the lungs of mice subjected to hemorrhage followed by septic challenge [24] . Based on these data, we sought to investigate the effects of silencing the local synthesis KC and MIP-2 by resident pulmonary cells. To assess the contribution of resident pulmonary cells to the production of these chemokines and the consequent influx of neutrophils to the lung, organ-specific suppression was produced by in vivo administration of small interfering RNA (siRNA) against KC or MIP-2. Gene silencing via RNA interference is an evolutionary, conserved mechanism involving cleavage of the posttranscriptional product, mRNA, by siRNA/RNA-induced silencing complexes complementary to the target mRNA. RNA interference has been identified in numerous species including plants, worms, and mammals [25] . To document the capacity of siRNA to inhibit local gene expression, in initial experiments, we exposed green fluorescent protein (GFP)-overexpressing, transgenic mice to intratracheal (i.t.) instillation of GFP siRNA. We observed marked suppression of pulmonary GFP expression but no change in liver GFP levels in our treatment group. Additionally, no increase in systemic or lung tissue interleukin (IL)-6 was detected in these mice or GFP background control mice that received GFP siRNA as compared with mice that received vehicle alone. Having found that chemokines derived from local tissue affect the recruitment of neutrophils to the lung, we hypothesized that a protocol that silenced local signaling for neutrophil recruitment would reduce hemorrhage-induced, neutrophil-mediated septic ALI. In addition, we hypothesized that local pulmonary gene-specific (KC or MIP-2) silencing would further elucidate the divergent roles played by these two chemokines in the pathogenesis of ALI.
MATERIALS AND METHODS

Mice
GFP-overexpressing mice, C57BL/6-TgN (Jackson Laboratory, Bar Harbor, ME), were used for assessment of efficacy of gene silencing via i.t. delivery of siRNA against GFP. Male C3H/HeN mice (Charles River Laboratories, Wilmington, MA), 7-9 weeks of age, were used in all experiments, which were performed in accordance with National Institutes of Health guidelines and approval from the Animal Use Committee of Rhode Island Hospital (Providence).
Reagents
KC and MIP-2 monoclonal capture antibody and secondary detection antibody for enzyme-linked immunosorbent assay (ELISA) were purchased from R&D Systems (Minneapolis, MN). Mouse IL-6 and IL-10 ELISA kits were purchased from BD PharMingen (San Diego, CA). Trimeric mixtures of custom-designed siRNA duplexes for KC and MIP-2 were synthesized by Dharmacon Research (Lafayette, CO). All other chemicals were analytical reagent grade and purchased from Sigma Chemical Co. (St. Louis, MO).
Mouse hemorrhage/sepsis model for ALI
Hemorrhage
The hemorrhage model we have used for these experiments has been described previously [5] . In brief, mice were anesthetized with methoxyflurane and restrained in supine position, and catheters were inserted into both femoral arteries. Anesthesia was discontinued, and blood pressure was continuously monitored through one catheter attached to a blood pressure analyzer (BPA, MicroMed, Louisville, KY). When fully awake, as determined by a mean blood pressure of ϳ95 mmHg, the mice were bled over a 5-to 10-min period to a mean blood pressure of 30 mmHg (Ϯ5 mmHg) and kept stable for 90 min. Immediately following hemorrhage, mice were resuscitated intravenously with Ringers lactate at 4ϫ drawn blood volume. Following resuscitation, arteries were ligated, catheters removed, and catheter sites sutured closed. Sham hemorrhage was performed as a control, and these mice were anesthetized, restrained, and their femoral arteries ligated, but no blood was drawn.
Polymicrobial sepsis
Twenty-four hours post-hemorrhage (or sham hemorrhage), sepsis was induced as a secondary challenge via cecal ligation and puncture (CLP) as described previously [5] . To summarize, mice were anesthetized with methoxyflurane and restrained in supine position. A 1-cm midline incision was made; the cecum was ligated with 5-0 silk thread and punctured twice with a 21-gauge needle. The cecum was then replaced, and the incision was sutured and lidocane applied, abdominal layer, then skin. Mice were resuscitated with 1 ml lactated Ringers solution subcutaneously and returned to their cages.
siRNA delivery was performed 2 h post-hemorrhage and was based on a protocol described by Kim et al. [27] . Mice were lightly anesthetized with methoxyflurane and suspended on a board in supine position at a 45°angle. A string anchored above their head in the inclined board was looped around their front teeth, and their body weight was supported by taping the base of their tail to the inclined board. Upon opening the jaw of the mouse, the tongue was gently drawn outward, opening the trachea. siRNA, specific for KC (duplex #1 AAAACGCUGGCUUCUGACAAC, duplex #2 AACAACCACUGUGCUA-GUAGA), MIP-2 (duplex #1 AACGAUUCGCUAAUUCACUGU, duplex #2 AAGCAGUCGGAUGGCUUUCAU), or GFP (GGCTACGTCCAGGAGCGCA-CC; 75 ug/mouse), was pipetted in vehicle, 100 ul saline, directly into the throat, momentarily blocking the mouse's airway. Inspiration by the mouse carried the siRNA and vehicle into the lung. The accuracy of siRNA delivery into the lung was confirmed by the infusion of Evan's Blue dye in the lungs of a control mouse.
Sample collection
Twenty-four hours post-CLP, mice were killed with an overdose of methoxyflurane.
Blood was collected via cardiac puncture into heparinized syringes. Blood samples were centrifuged, and plasma was collected and stored at -70°C for later cytokine analysis.
Lung tissue was harvested for assessment of cytokine levels, myeloperoxidase (MPO), reverse transcriptase-polymerase chain reaction (RT-PCR), neutrophil influx (esterase ؉ cells), and tissue architecture. Samples for ELISAs, MPO, and RT-PCR were collected in potassium buffer or TriPure reagent for processing. For histological assessment, the trachea was cannulated, and lungs were inflated to 25 cm pressure with formalin. Lungs were excised and snap-frozen in liquid nitrogen in embedding molds with optical cutting temperature compound media (TissueTek, Elkhart, IL) for later processing of frozen sections.
Methods of assessment
Cytokine and chemokine ELISAs for IL-6, IL-10, KC, MIP-2, and tumor necrosis factor ␣ (TNF-␣) were performed as per the manufacturer's protocol on lung tissue homogenates collected from experimental mice.
Lung MPO activity, as an assessment of neutrophil influx, was measured according to established protocols [19] . Briefly, lung tissue was homogenized in 0.5 ml 50 mM potassium phosphate buffer, pH 7.4, and centrifuged at 40,000 g at 4°C for 30 min. The supernatant was reserved for cytokine analysis. The remaining pellet was resuspended in 0.5 ml 50 mM potassium buffer, pH 6.0, with 0.5% hexadecyltrimethylammonium bromide, sonicated on ice, and then centrifuged at 12,000 g at 4°C for 10 min. Supernatants were then assayed at a 1:20 dilution in reaction buffer (530 nmol/L o-dianisidine, 150 nmol/L H 2 O 2 in 50 mM potassium phosphate buffer) and read at 490 nm.
RNA extraction and cDNA synthesis were performed on lung tissue sections harvest from sample groups. For detection of KC and MIP-2, total RNA was isolated using TriPure reagent and isolation protocol from Boehringer Mannheim (Gaithersburg, MD). Briefly, lung tissue was homogenized in 1.0 ml TriPure reagent, 0.2 ml chloroform was added to each sample, and samples were then shaken, incubated for 2-5 min at room temperature, and centrifuged for 15 min at 12,000 g and 4°C. Following centrifugation, the colorless upper aqueous phase was transferred to a new 2.0-ml centrifuge tube, and RNA was precipitated by adding 0.5 ml isopropanol, incubating sample 5-10 min at room temperature, and centrifuging 10 min at 12,000 g and 4°C. RNA pellet was washed twice in 75% ethanol, air-dried, and resuspended in RNase-free water (0.05 ml) for calculation of RNA concentration. IScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA) was for reverse transcription of RNA to generate cDNA. PCR was performed (30 cycles, 2 ul cDNA per sample) using custom primers (Integrated DNA Technologies, Coralville, IA) for KC (5Ј-AGAAGACAGACTGCTCTGATGGCA-3Ј forward and 5Ј-AATGTCCAAGGGAAGCGTCAACAC-3Ј reverse) and MIP-2 (5Ј-TGCCTGAAGACCCTGCCAAGG-3Ј forward and 5Ј-GTTAGCCTTGC-CTTTGTTCAG-3Ј reverse).
Immunohistochemical staining for assessment of neutrophil influx and tissue architecture
Staining for leukocyte-specific esterase, Naphthol AS-D chloroacetate esterase (Sigma Diagnostics, St. Louis, MO) was performed on frozen tissue sections and fixed in citrate-acetone-formaldehyde. Slides were incubated in a solution of sodium nitrate, Fast Red Violet BL base solution, TRIZMAL 6.3 buffer, and Naphthol AS-D chloroacetate solution in deionized water for 15 min at 37°C. Following rinsing, slides were counterstained with Gills hemotoxylin solution and cover-slipped. Stained lung sections were examined microscopically for morphology and positively stained cells. To establish the total number (%) of cells (per field) that were neutrophils (esterase ϩ) present in the sample, tissue sections were randomly screened (seven to eight fields/slide) at 400ϫ (25 m 2 /field).
Statistical analysis
Data were expressed as mean Ϯ SEM of five mice examined in each group. Statistical error was determined using One-Way ANOVA, and the post-hoc test was Tukey's. Calculations were performed using SigmaStat for Windows, Version 2.03. P values Ͻ0.05 were considered significant.
RESULTS
i.t. delivery of siRNA against GFP suppresses fluorescence in lung tissue of GFP-transgenic, overexpressing mice
To establish the efficacy of delivery and siRNA suppression, GFP siRNA was given i.t. to mice overexpressing GFP. Lung tissue histology representative of the treatment groups shows marked suppression in GFP in the lung tissue from treated mice as compared with the mice given only saline vehicle i.t. (Fig. 1, A and B) . As a tissue-specificity control, liver sections from the GFP siRNA-treatment group were assessed for changes in fluorescence intensity. No changes in GFP intensity were observed in the livers from the treated mice (data not shown).
RT-PCR shows marked suppression of mRNA for targeted proteins
RT-PCR products from KC and MIP-2 siRNA-treated mouse lung tissue show a partial suppression of their respective mRNAs relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Fig. 2, A and B) . The relative intensity of each PCR product band was assessed, and a median intensity per group was graphically generated. Suppression in relative intensity in mRNA for the KC and MIP-2 siRNA-treated mice is observed.
Lung tissue levels of IL-6 significantly reduced following suppression of local expression of KC and MIP-2
In mice given a saline vehicle immediately following hemorrhage prior to CLP, lung tissue levels of IL-6 increase threefold compared with the Sham/Hem group. Local suppression with siRNA of KC and MIP-2 expression produced significant reductions in IL-6 levels in the lung of both of these treatment groups (Fig. 3A) .
Local suppression of MIP-2 expression reduced systemic levels of IL-6 to Sham/Hem group levels Systemic levels of IL-6 significantly increase in saline-treated mice subjected to hemorrhage and sepsis. Suppression of MIP-2 in lung tissue via siRNA interference markedly reduced systemic levels of IL-6 when compared with the saline Hem/ CLP group. In contrast, no changes were observed in the lungs of mice in which KC expression was suppressed (Fig. 3B ).
Tissue levels show suppressed chemokine levels for respective treatment groups
Lung tissue levels of KC and MIP-2 are significantly elevated following hemorrhage and sepsis. Local suppression, via siRNA treatment, reduced levels of KC and MIP-2 in the lungs of mice receiving these treatments (Fig. 4, A and B) .
Systemic levels of KC and MIP-2 affected in a differential manner by local silencing
Local silencing of KC and MIP-2 decreased systemic levels of KC below the saline Hem/CLP group (Fig. 5A) . In contrast, systemic MIP-2 remained elevated to saline Hem/CLP group levels in both siRNA treatment groups (Fig. 5B ).
TNF-␣ levels not reduced by local silencing of KC or MIP-2
The effects of local silencing of KC and MIP-2 on systemic and lung tissue levels of TNF-␣ were assessed. In the lung tissue, local suppression of MIP-2 produced an increase in TNF-␣ as compared with the saline Hem/CLP group; the KC suppression group levels did not differ from saline Hem/CLP (Fig. 6A) . In contrast, neither local silencing of KC nor MIP-2 produced a change significant to the saline Hem/CLP group levels (Fig. 6B ).
Local silencing of MIP-2 significantly decreased MPO enzyme activity MPO activity was used as a measure of neutrophil influx to lung tissue. Local silencing of MIP-2 decreased MPO in these mice lungs to Sham/Hem group levels. MPO levels in the KC treatment group were not similarly decreased (Fig. 7) .
Lung tissue histology supports MPO activity data
Lung tissue sections were stained for a neutrophil-specific esterase and assessed microscopically for esterase-positive staining cells, tissue architecture, and cellular infiltrate. Local suppression of MIP-2, in agreement with MPO activity, reduced neutrophil influx, interstitial edema, congestion, and disruption of lung tissue architecture (Fig. 8) .
DISCUSSION
The recruitment of neutrophils to the lungs is crucial for host defense against invading pathogens. In trauma patience exposed to a secondary infectious challenge, however, neutrophil targeting and sequestration in the lung are associated with tissue injury, compromised lung function, and the development of ALI [4, 7, 9, 16, 20] . Studies by our laboratory and others have focused on the role of chemokines in the pathogenesis of neutrophil-associated ALI [8, 15, 17, 19] .
In this study, we used a mouse model of hemorrhagic shock followed by infectious challenge to assess the effects of using a post-shock/sepsis local pulmonary siRNA silencing of KC and MIP-2 on the development of ALI. We hypothesized that the neutrophil-mediated lung injury observed following hemorrhage and subsequent septic challenge would be attenuated as a result of a disruption of neutrophil targeting to the lung via chemokine gradient originating from local pulmonary cells. In addition, we hypothesized that local pulmonary gene-specific silencing of KC or MIP-2, chemokines that share a common CXC chemokine receptor 2 (CXCR2) affinity [27] and have been suggested to be redundant [28, 29] , would clarify their contribution to the pathogenesis of ALI.
Local silencing was assessed using siRNA against GFP in GFP-transgenic, overexpressing mice. The treatment dose of 75 ug/mouse/i.t. was derived from the lowest concentration observed to produce detectable suppression in fluorescence in lung tissue from GFP mice. In addition, the tissue specificity for i.t. siRNA delivery was confirmed in liver tissue sections from GFP siRNA-treated mice. No suppression of GFP fluorescence was observed in the liver sections from mice that received local administration of GFP siRNA. Mice given GFP siRNA were assessed for extraneous inflammatory response to the siRNA by comparison of IL-6 levels among treated mice, mice given saline vehicle i.t., and GFP-transgenic background mice given siRNA against GFP. Lung tissue IL-6 levels were not significantly different among the treatment groups (data not shown). To assess the capacity of in vivo administration of siRNA to induce an interferon (IFN) response, our laboratory [30] and others [31] have measured IFN-␣ in the plasma of mice given up to 2.5 mg/kg (10%) body weight, siRNA via hydrodynamic tail vein injection. Levels of IFN-␣ were found to be similar to untreated/naïve animals.
Lung tissue-specific gene silencing via siRNA against KC and MIP-2 produced similar and divergent effects in the inflammatory response of the hemorrhaged/septic mice. Lung tissue IL-6, although reduced following local siRNA silencing of both chemokines, was reduced two times as much in the KC-silenced group. This finding is different from antibody neutralization studies previously reported by our laboratory, where neutralization of MIP-2 produced a similar or marginally greater suppression of lung tissue IL-6 compared with KC [19] . One explanation could be the local delivery/targeting and specificity of treatment using siRNA. Local gene silencing via siRNA targets the synthesis of the specific chemokine by resident pulmonary cells, where systemic antibody neutralization blocks existing chemokines in the blood. In our shock/ sepsis model, the induction of sepsis creates an inflammatory focus within the peritoneum from which inflammatory mediators are released into the circulation [5, 18] . These mediators further stimulate an immune system previously sensitized by hemorrhagic shock. The specific cell population(s) in the lung targeted by the i.t. delivery of siRNA are not known at this time. Pulmonary macrophages are believed to be a primary source of local MIP-2 in the lung [24, 32] , and fibroblasts [33] and eosinophils [34] have been associated with KC synthesis. A reduction in lung tissue proinflammatory cytokine, IL-6, along with reduced neutrophil influx could potentially translate into a general reduction as a result of a reduced lung inflammatory response of systemic IL-6. Although systemic IL-6 levels showed a significant decrease in the MIP-2-silenced group, no change was observed in the KC group compared with saline Hem/CLP.
As anticipated, lung tissue levels of KC and MIP-2 were reduced in mice that were given siRNA to silence local expression of those chemokines by resident pulmonary cells. Similar results were not observed in the plasma. In KC and MIP-2 treatment groups, a reduction of plasma KC was observed, and neither KC nor MIP-2 local silencing produced a reduction in plasma MIP-2. These findings suggest that circulating/plasma levels of MIP-2 are more likely to be associated with the inflammatory environment of the peritoneal cavity as a result of CLP than a release into circulation from the lung. A reduction in systemic levels of KC via siRNA silencing points to a selective transport of chemokines into the circulation in response to inflammatory stimuli, as reported by Quinton et al. [35] , who found through 125-I-labeling of i.t. administered recombinant cytokine-induced neutrophil chemoattractant (rCINC) that a rat neutrophil chemokine corresponding to murine KC, which labeled CINC in circulating blood, rose to 200 times above base levels within 1 h following instillation. However, a similar elevation of circulating/plasma MIP-2 levels was not found when 125-I labeled rMIP-2 was administered i.t. [35] . Additionally and relative to circulating chemokine concentrations, although KC and MIP-2 share a common receptor on mouse neutrophils (CXCR2), and receptor desensitization has been observed when ligand concentrations are at saturating levels, the fact that KC has a significantly lower receptor affinity than MIP-2 suggests that elevated MIP-2 levels, as opposed to KC plasma levels, would serve to desensitize the CXCR2 and subsequently suppress neutrophil migration into the lung. Consistent with Quinton and co-workers' data [35] , decreased levels of systemic KC following local silencing were observed in our study, and systemic MIP-2 was not effected.
TNF-␣ is an early mediator of the inflammatory response, upstream of the chemokines, KC, and MIP-2. Levels of TNF-␣ in lung tissue and plasma were measured in siRNA-treatment groups as a control for comparison of inflammatory signaling. As would be anticipated, no significant changes in TNF-␣ were observed.
A clear divergence in the effects of silencing local chemokine expression was observed in the significant reduction of MPO activity in lung tissue from mice that received siRNA to silence local expression of MIP-2. These findings are consistent with our previous studies, where antibody neutralization of MIP-2 reduced MPO to Sham/Hem levels [19] . Supporting these MPO data is lung tissue histology, showing a decrease in cellular infiltrate, interstitial edema, and disruption of lung tissue architecture.
The scientific/research community is just beginning to understand the complexity of RNA interference and recognize its potential as an in vivo therapeutic tool. Song et al. [36] have shown that Fas siRNA silencing can be protective in preventing murine hepatocytes from apoptosis, and Tompkins et al. [37] have protected mice from lethal challenge with influenza virus. Still, questions involving siRNA design, efficacy of delivery, long-term toxicity, mutagenesis in cells that take-up the siRNA, and the specific cells targeted by siRNA remain for future investigation.
This current study as well as studies from other laboratories suggest that local production of MIP-2 by resident pulmonary cells constitutes an integral regulator of neutrophil influx [8, 33, 38, 39] . Having said this, we have also presented data here that suggest that the local/pulmonary production of MIP-2 as well KC contribute to the systemic, inflammatory cytokine environment in our model of hemorrhage-induced neutrophil priming for ALI.
Our data suggest that i.t. delivery of siRNA produces ϳ40% suppression in local chemokine expression in lung tissue. Future experiments will need to be performed to first identify the target cells for siRNA gene silencing and second, to further elucidate the nature of all the changes in proinflammation, neutrophil targeting, and lung injury, which we have observed in our hemorrhage/sepsis model of murine ALI at higher concentrations of siRNA. However, based on our current study, it is our belief that like KC and MIP-2, other genes involved in such pulmonary pathology may be amenable to this type of siRNA approach, thus offering a potential therapeutic strategy for the treatment of ALI. 
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